India is Racing to Bring a COVID-19 Vaccine by Mid-August

As India races to bring COVID-19 vaccine by mid-August, the government said that two vaccines called COVAXIN and ZyCov-D are entering the human trial stage, which marks the beginning of the end.

Approval for human clinical trials for two COVID-19 vaccines known as COVAXIN and ZyCov-D, which is made in India marks the "beginning of the end" for the novel coronavirus pandemic that has infected more than 1.12 crore people worldwide.

Along with the two Indian efforts, the world over, 11 out of 140 vaccine candidates have entered the human trial phase.

Coronavirus
Coronaviruses infect animals, humans, and birds. Human coronaviruses, such as SARS, MERS, and 2019-nCoV cause respiratory distress and even death. The S protein is the infectious agent of the virus.

‘COVAXIN and ZyCov-D vaccine is India's own efforts to bring a vaccine for this pandemic ’

It also said that six Indian companies are working on a vaccine for COVID-19.

Allaying speculations about India's ability, the ministry of science and technology said, "In the past years, India has emerged as one of the significant vaccine manufacturing hubs. Indian manufacturers account for 60 percent of vaccine supplies made to UNICEF." It added that regardless of which nation comes up with the COVID vaccine, they will have to depend on India for its ability for mass production.

Stressing the crucial role India plays in the vaccine, the government cited how two key players have inked contracts with India. Both -- AAZD1222 developed by Jenner Institute of the University of Oxford and licensed to AstraZeneca; and The MRNA-1273 vaccine developed by Kaiser Permanente Washington Health Research Institute "inked an agreement with Indian manufacturers for production of the COVID vaccines."

Coronavirus: Mother-to-Child Vertical Transmission Routes Identified
Vertical transmission routes of coronavirus from mother to newborn have been identified and defined with more clarity. The transmission happens when the mother is pregnant with the baby, soon after delivery or by superficial exposure to coronavirus.

Talking about how Covaxin works, the ministry in a press statement explained, "The Bharat Biotech's COVAXIN uses the virus isolated from an Indian patient by the National Institute of Virology to develop the inactivated virus vaccine."

Earlier on July 2, the Indian Council of Medical Research (ICMR) head Dr. Balram Bhargava wrote to 12 trial sites for the Covid-19 vaccine candidate, Covaxin, stating that all clinical trials need to be completed by August 15.

Latest Study Shows How Indians are Practicing Social Distancing to Fight the Coronavirus
India is under strict lockdown and over 50,000 coronavirus cases are in the country. The entire nation has been cautiously quarantining themselves to stop the spread of COVID-19. Social distancing remains the most effective tool against the pandemic.

Source-IANS

Watch Out: Deadly Coronavirus may Lurk in Kids� Toys and Play Equipment
Stay away from playgrounds: COVID-19 can stick on to kids’ toys and play equipment. So, make your naughty kids to play indoors and avoid sharing toys to keep coronavirus at bay.